Cargando…

Detection of Putative Stem-cell Markers in Invasive Ductal Carcinoma of the Breast by Immunohistochemistry: Does It Improve Prognostic/Predictive Assessments?

INTRODUCTION: Experimental evidences from the last 2 decades supports the existence of a special type of neoplastic cell with stem-like features [cancer stem cell (CSC)] and their role in the pathophysiology and therapeutic resistance of breast cancer. However, their clinical value in human breast c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Oliveira, Rodrigo V., Souza, Valéria B., Souza, Philipi C., Soares, Fernando A., Vassallo, José, Rocha, Rafael M., Schenka, André A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2018
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6250294/ https://www.ncbi.nlm.nih.gov/pubmed/28719381 http://dx.doi.org/10.1097/PAI.0000000000000513

Ejemplares similares

Cancer Stem and Progenitor-Like Cells as Pharmacological Targets in Breast Cancer Treatment
por: de Souza, Valéria B., et al.
Publicado: (2015)

Immunostaining with D2–40 improves evaluation of lymphovascular invasion, but may not predict sentinel lymph node status in early breast cancer
por: Britto, Anna V, et al.
Publicado: (2009)

Prognostic ability of a panel of immunohistochemistry markers – retailoring of an 'old solution'
por: Brennan, Donal J, et al.
Publicado: (2008)

Evaluation of endometrial carcinoma prognostic immunohistochemistry markers in the context of molecular classification
por: Karnezis, Anthony N, et al.
Publicado: (2017)

Electrical field-induced contractions on Crotalus durissus terrificus and Bothrops jararaca aortae are caused by endothelium-derived catecholamine
por: Campos, Rafael, et al.
Publicado: (2018)

Glut1 and Glut3 as Potential Prognostic Markers for Oral Squamous Cell Carcinoma
por: Ayala, Fernanda Rocha Rojas, et al.
Publicado: (2010)

A Meta-Analysis of SMAD4 Immunohistochemistry as a Prognostic Marker in Colorectal Cancer()()
por: Voorneveld, Philip W., et al.
Publicado: (2015)

An exploration of immunohistochemistry-based prognostic markers in patients undergoing curative resections for colon cancer
por: Bennedsen, Astrid Louise Bjørn, et al.
Publicado: (2022)

Association between Immunohistochemistry Markers and Tumor Features and Their Diagnostic and Prognostic Values in Intrahepatic Cholangiocarcinoma
por: He, Jiannan, et al.
Publicado: (2022)

ROCK1 as a novel prognostic marker in vulvar cancer
por: Akagi, Erica M, et al.
Publicado: (2014)

MUC1 as a Putative Prognostic Marker for Prostate Cancer
por: Strawbridge, Rona J, et al.
Publicado: (2008)

Immunohistochemistry profiles of breast ductal carcinoma: factor analysis of digital image analysis data
por: Laurinavicius, Arvydas, et al.
Publicado: (2012)

Upregulation of junctional adhesion molecule-A is a putative prognostic marker of hypertension
por: Xu, Haibo, et al.
Publicado: (2012)

Immunohistochemical profile of high-grade ductal carcinoma in situ of the breast
por: Perez, Amanda Arantes, et al.
Publicado: (2013)

The prognostic value of the stem-like group in colorectal cancer using a panel of immunohistochemistry markers
por: Ong, Chee Wee, et al.
Publicado: (2015)

Retracted: Association between Immunohistochemistry Markers and Tumor Features and Their Diagnostic and Prognostic Values in Intrahepatic Cholangiocarcinoma
por: Methods in Medicine, Computational and Mathematical
Publicado: (2023)

Bioinformatic evidences and analysis of putative biomarkers in pancreatic ductal adenocarcinoma
por: Gu, Yuan, et al.
Publicado: (2019)

Combination immunohistochemistry for SMAD4 and Runt-related transcription factor 3 may identify a favorable prognostic subgroup of pancreatic ductal adenocarcinomas
por: Lee, Yangkyu, et al.
Publicado: (2017)

Reg proteins promote acinar-to-ductal metaplasia and act as novel diagnostic and prognostic markers in pancreatic ductal adenocarcinoma
por: Li, Qing, et al.
Publicado: (2016)

PROX1 and β-catenin are prognostic markers in pancreatic ductal adenocarcinoma
por: Saukkonen, Kapo, et al.
Publicado: (2016)

PRSS3 is a prognostic marker in invasive ductal carcinoma of the breast
por: Qian, Li, et al.
Publicado: (2017)

Is Carboxypeptidase B1 a Prognostic Marker for Ductal Carcinoma In Situ?
por: Kothari, Charu, et al.
Publicado: (2021)

LKB1 Loss Assessed by Immunohistochemistry as a Prognostic Marker to First-Line Therapy in Advanced Non-Small-Cell Lung Cancer
por: Avilés-Salas, Alejandro, et al.
Publicado: (2022)

Pancreatic ductal adenocarcinoma ubiquitination profiling reveals specific prognostic and theranostic markers
por: El Kaoutari, Abdessamad, et al.
Publicado: (2023)

Prognostic assessment of hypoxia and metabolic markers in cervical cancer using automated digital image analysis of immunohistochemistry
por: Kim, Bo Wook, et al.
Publicado: (2013)

RECK is not an independent prognostic marker for breast cancer
por: Gomes, Luciana R., et al.
Publicado: (2015)

ERG Immunohistochemistry as an Endothelial Marker for Assessing Lymphovascular Invasion
por: Kim, Sehun, et al.
Publicado: (2013)

Prevalence and Molecular Profile of Breast Carcinoma Using Immunohistochemistry Markers in Mexican Women
por: Macari, Andres, et al.
Publicado: (2021)

Putative stem cells and epithelial-mesenchymal transition revealed in sections of ovarian tumor in patients with serous ovarian carcinoma using immunohistochemistry for vimentin and pluripotency-related markers
por: Kenda Suster, Natasa, et al.
Publicado: (2017)

Diagnostic and prognostic implications of parafibromin immunohistochemistry in parathyroid carcinomaT
por: Pyo, Jung-Soo, et al.
Publicado: (2019)

Assessment of beta-catenin expression by immunohistochemistry in colorectal neoplasms and its role as an additional prognostic marker in colorectal adenocarcinoma
por: Bhattacharya, Indroneel, et al.
Publicado: (2019)

Prognostic significance of natural killer cell-associated markers in gastric cancer: quantitative analysis using multiplex immunohistochemistry
por: Na, Hee Young, et al.
Publicado: (2021)

Prognostic significance of c-KIT in vulvar cancer: bringing this molecular marker from bench to bedside
por: de Melo Maia, Beatriz, et al.
Publicado: (2012)

Comparative assessment between objective and subjective methods in slides stained by immunohistochemistry
por: de Andrade Quintanilha Ribeiro, Fernando, et al.
Publicado: (2015)

Morphological characterization of a human glioma cell l ine
por: Machado, Camila ML, et al.
Publicado: (2005)

Expression sites of immunohistochemistry markers in oral diseases – A scoping review
por: Prabakaran, Rebekah C., et al.
Publicado: (2022)

Prognostic implications of immunohistochemistry markers for EGFR-TKI therapy in Chinese patients with advanced lung adenocarcinoma harboring EGFR mutations
por: Zhang, Ruiguang, et al.
Publicado: (2016)

Evaluation of natural killer cell (CD57) as a prognostic marker in oral squamous cell carcinoma: An immunohistochemistry study
por: Agarwal, Rashmi, et al.
Publicado: (2016)

Validation of commercial Mas receptor antibodies for utilization in Western Blotting, immunofluorescence and immunohistochemistry studies
por: Burghi, Valeria, et al.
Publicado: (2017)

Immunohistochemistry
por: HAWES, DEBRA, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_h172kt4jhioeel2eb6cteb0ekf